Cullen/Frost Bankers, Inc. Abbott Laboratories Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 167,778 shares of ABT stock, worth $21.7 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

167,778

Previous 172,962 3.0%

Holding current value

$21.7 Million

Previous $18 Million 6.43%

% of portfolio

0.26%

Previous 0.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$100.07 - $118.13 $518,762 - $612,385	-5,184 Reduced 3.0%	167,778 $19.1 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $8.84 Million - $9.87 Million	-87,740 Reduced 33.66%	172,962 $18 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $680,338 - $751,403	-6,212 Reduced 2.33%	260,702 $29.6 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $550,249 - $673,550	-6,101 Reduced 2.23%	266,914 $29.4 Million
Q3 2023 Nov 02, 2023	BUY	$95.53 - $114.62 $199,180 - $238,982	2,085 Added 0.77%	273,015 $26.4 Million
Q2 2023 Aug 04, 2023	SELL	$100.78 - $112.29 $1.78 Million - $1.98 Million	-17,676 Reduced 6.12%	270,930 $29.5 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $874,355 - $1.03 Million	9,027 Added 3.23%	288,606 $29.2 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $5.32 Million - $6.24 Million	55,975 Added 25.03%	279,579 $30.7 Million
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $469,576 - $543,681	4,853 Added 2.22%	223,604 $21.6 Million
Q2 2022 Aug 05, 2022	SELL	$102.07 - $123.37 $126,770 - $153,225	-1,242 Reduced 0.56%	218,751 $23.8 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $686,742 - $837,437	6,023 Added 2.81%	219,993 $26 Million
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $2.05 Million - $2.51 Million	-17,773 Reduced 7.67%	213,970 $30.1 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $687,594 - $760,679	-5,894 Reduced 2.48%	231,743 $27.4 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $339,056 - $399,118	3,205 Added 1.37%	237,637 $27.5 Million
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $395,633 - $466,116	3,635 Added 1.57%	234,432 $28.1 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $726,285 - $791,443	6,917 Added 3.09%	230,797 $25.3 Million
Q3 2020 Nov 05, 2020	BUY	$91.64 - $111.29 $552,864 - $671,412	6,033 Added 2.77%	223,880 $24.4 Million
Q2 2020 Aug 05, 2020	BUY	$76.57 - $98.0 $3.54 Million - $4.53 Million	46,249 Added 26.95%	217,847 $19.9 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $7.9 Million - $11.6 Million	125,749 Added 274.27%	171,598 $13.5 Million
Q4 2019 Feb 06, 2020	BUY	$78.51 - $87.4 $368,447 - $410,168	4,693 Added 11.4%	45,849 $3.98 Million
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $23,324 - $25,290	285 Added 0.7%	41,156 $3.44 Million
Q2 2019 Aug 01, 2019	SELL	$72.88 - $85.0 $56,846 - $66,300	-780 Reduced 1.87%	40,871 $3.44 Million
Q1 2019 Apr 30, 2019	BUY	$66.22 - $80.06 $70,855 - $85,664	1,070 Added 2.64%	41,651 $3.33 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $103,125 - $116,826	-1,573 Reduced 3.73%	40,581 $2.94 Million
Q3 2018 Oct 29, 2018	SELL	$60.81 - $73.36 $105,870 - $127,719	-1,741 Reduced 3.97%	42,154 $3.09 Million
Q2 2018 Jul 27, 2018	SELL	$57.57 - $63.54 $248,414 - $274,175	-4,315 Reduced 8.95%	43,895 $2.68 Million
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $115,691 - $130,802	-2,056 Reduced 4.09%	48,210 $2.89 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $174,728 - $187,064	-3,255 Reduced 6.08%	50,266 $2.87 Million
Q3 2017 Nov 02, 2017	BUY	$48.06 - $53.64 $2.57 Million - $2.87 Million	53,521	53,521 $2.86 Million

Others Institutions Holding ABT

# of Institutions

3,206

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $227B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Abbott Laboratories Transaction History